Kanagawa, Japan

Yoshimi Satoh

This inventor holds 1 USPTO granted patent. Top assignees: Nippon Steel Chemical Co., Ltd., Nippon Steel Corporation. Active years: 1999.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Yoshimi Satoh. Retrieved from https://idiyas.com/inventor/yoshimi-satoh-rhukl0gy

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

Average Co-Inventor Count = 8.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 1999

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of Yoshimi Satoh

Introduction

Yoshimi Satoh is a notable inventor based in Kanagawa, Japan. She has made significant contributions to the field of pharmaceuticals, particularly with her work on fibrinogen receptor antagonists. Her innovative approach has led to advancements in medical treatments.

Latest Patents

Yoshimi Satoh holds 1 patent for her invention titled "Fibrinogen receptor antagonist and pharmaceutical compositions." This patent includes compounds of a specific general formula and pharmaceutically acceptable salts, showcasing her expertise in developing new therapeutic agents.

Career Highlights

Throughout her career, Satoh has worked with prominent companies such as Nippon Steel Corporation and Nippon Steel Chemical Co., Ltd. Her experience in these organizations has allowed her to refine her skills and contribute to groundbreaking research in her field.

Collaborations

Yoshimi Satoh has collaborated with esteemed colleagues, including Takeo Harada and Akira Tachiki. These partnerships have fostered a creative environment that has led to innovative solutions in pharmaceutical development.

Conclusion

Yoshimi Satoh's contributions to the field of pharmaceuticals through her patents and collaborations highlight her role as a significant inventor. Her work continues to influence advancements in medical science.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…